Download Buruli Ulcer

Survey
yes no Was this document useful for you?
   Thank you for your participation!

* Your assessment is very important for improving the work of artificial intelligence, which forms the content of this project

Document related concepts
no text concepts found
Transcript
Buruli Ulcer
Arwen Frick-Cheng
Bio 402
What is Buruli Ulcer?
• Infectious disease
• Characterized by the WHO as a Neglected
Tropical Diseases (NTD)
▫ 14 NTD
▫ Widely disregarded by industrial nations
What is Buruli Ulcer?
Regions/People Affected
• Tropical wetlands and rainforest
▫ Mainly: West and Central Africa
•
•
•
•
Associated with bodies of stagnant water
The immunocompromised
The poor
Children
Causative Agent
• Mycobacterium ulcerans
• Related to Tuberculosis, Leprosy
Colonies of Mycobacterium ulcerans.
http://www.public.asu.edu/~shaydel/research_002buruli.html
Identification of Bacteria
•
•
•
•
Acid Fast Stain
Selective Culture
Histopathology
PCR
Acid-fast stain of Mycobacterium ulcerans.
http://www.who.int/buruli/information/diagnosis/en/index14.html
Symptoms
• Long latent period
• Usually on exposed
body parts
• Four stages
Virulence Factor
• Toxin: Mycolactone
▫ Immunosupressant
▫ Necrosis
Treatment
• Antibiotic
▫ Rifampicin
• Surgical removal/amputation
• Vaccination (BCG)
• Alternatives
▫ Heat treatment
▫ French Clay
▫ Topical nitrogen oxides
• Will slowly heal on its own
Effects
• Heavy scarring
▫ Contracture of limbs
▫ Blindness
• secondary infections
References
• Neglected Diseases Caused By Bacterial
Infections. M. Bechtle, S. Chen and T. Efferth.
Current Medicinal Chemistry, 2010, 17, 42-60
• Laboratory diagnosis of Buruli ulcer disease.
Marcus Beissner, Karl-Heinz Herbinger & Gisela
Bretzel . Future Science Group
• Mycolactone Inhibits Monocyte Cytokine
Production by a Posttranscriptional
Mechanism. Rachel E. Simmonds et al. J.
Immunol. 2009;182;2194-2202
Related documents